NYBC Ventures, a specialized fund focused on investments in blood and cellular technologies, announced today the formation of its limited liability company structure and the addition of four esteemed industry leaders to its newly-constituted Board of Managers. This critical step advances NYBC Ventures’ mission of accelerating groundbreaking life science innovations and expanding New York Blood Center Inc.’s (NYBCe) influence within the blood and cell-related ecosystems.
